Exosome Diagnostic And Therapeutic Market Scope And Analysis

  • Report Code : TIPRE00005514
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Exosome Diagnostics and Therapeutics Market Scope and Analysis by 2031

Buy Now

Exosome Diagnostics and Therapeutics Market Report Exosome Diagnostics and Therapeutics Market Size and Share Exosome Diagnostics and Therapeutics Market Scope and Analysis

Exosome Diagnostics and Therapeutics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 76.03 Million
Market Size by 2031 US$ 1542.45 Million
Global CAGR (2023 - 2031) 35.1%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Diagnostic
  • Therapeutic
By Service
  • Instrument
  • Reagents
  • Software
By End User
  • Cancer Institutes
  • Hospitals
  • Diagnostic Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Aethlon Medical Inc
  • Therapeutic Solutions International Inc
  • ReNeuron Group plc
  • Immune Therapy Holdings AB
  • Cell Guidance Systems LLC
  • BioRegenerative Sciences
  • Evomic Science LLC
  • Norgen Biotek Corp
  • Exosome Diagnostics Inc
  • Bio Techne

    • Exosome Diagnostics and Therapeutic Market News and Recent Developments

    The exosome diagnostics and therapeutics market is evaluated by gathering qualitative and quantitative data post post-primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for exosome diagnostics and therapeutic strategies:

    • In July 2023, Texas–based Direct Biologics announced promising results from a Phase II trial showing that its exosome, ExoFlo, reduced mortality in long COVID patients with acute respiratory distress syndrome. (Source: Company Press Release)
    • In January 2024, EXO Biologics SA, a Belgian biotech company that develops biopharmaceuticals using exosomes to treat rare diseases, launched ExoXpert, a contract development and manufacturing organization (CDMO) specializing in exosomes. (Source: Company Press Release)

    Exosome Diagnostics and Therapeutic Market Report Coverage and Deliverables

    The “Exosome Diagnostics and Therapeutic Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles